Targeted Delivery of Growth Factors by HSV-Mediated Gene Transfer for Peripheral Neuropathy

E-ISSN： 1875-5631|13|5|315-321

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.13, Iss.5, 2013-01, pp. : 315-321

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Assessment In Vitro of a Novel Therapeutic Strategy for Glioma, Combining Herpes Simplex Virus HSV1716-mediated Oncolysis with Gene Transfer and Targeted Radiotherapy

Medicinal Chemistry, Vol. 1, Iss. 5, 2005-09 ,pp. : 423-429

Bentham Science Publishers

Access to resources Recommend Favorite

Ligand-targeted receptor-mediated vectors for gene delivery

By Deonarain M.P.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 1, 1998-01 ,pp. : 53-69

Informa Healthcare

Access to resources Recommend Favorite

Growth Factors as Therapeutics for Diabetic Neuropathy

Current Drug Targets, Vol. 9, Iss. 1, 2008-01 ,pp. : 47-59

Bentham Science Publishers

Access to resources Recommend Favorite

HSV-1-Derived Recombinant and Amplicon Vectors for Gene Transfer and Gene Therapy

Current Gene Therapy, Vol. 5, Iss. 5, 2005-10 ,pp. : 445-457

Bentham Science Publishers

Access to resources Recommend Favorite

Applications of Gene Transfer to Targeted Radiotherapy

Current Pharmaceutical Design, Vol. 6, Iss. 14, 2000-09 ,pp. : 1419-1432

Bentham Science Publishers

Access to resources Recommend Favorite